- Home
- ABVC vs QTTB Comparison
ABVC vs QTTB Comparison
Compare ABVC & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABVC | QTTB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 44.3M |
| IPO Year | 2009 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ABVC | QTTB |
|---|---|---|
| Price | $1.27 | $5.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 49.4K | ★ 201.4K |
| Earning Date | 03-03-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.14 | ★ 136.78 |
| EPS | N/A | ★ 2.42 |
| Revenue | $509,589.00 | ★ $53,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.65 | $1.38 |
| 52 Week High | $4.02 | $7.80 |
Technical Indicators
Market Signals| Indicator | ABVC | QTTB |
|---|---|---|
| Relative Strength Index (RSI) | 33.79 | 59.59 |
| Support Level | $1.15 | $1.64 |
| Resistance Level | $1.74 | $6.37 |
| Average True Range (ATR) | 0.13 | 0.68 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 13.15 | 47.52 |
Price Performance
Historical ComparisonAbout ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
About QTTB Q32 Bio Inc.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.